Reprint
Advances in Molecular Genetics of Brain Tumors
Edited by
February 2023
242 pages
- ISBN978-3-0365-6644-3 (Hardback)
- ISBN978-3-0365-6645-0 (PDF)
This book is a reprint of the Special Issue Advances in Molecular Genetics of Brain Tumors that was published in
Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary
This reprint encompasses a number of articles that focus on the molecular blueprint of brain tumors. A collection of relevant papers in the rapidly expanding field of brain tumor molecular genetics broadens our knowledge about the biology of brain tumors, and inspires further studies that will improve the diagnosis and clinical management of brain tumors. Due to the great heterogeneity of brain tumors it is important to research and understand every aspect of their initiation, progression and metastasis in order to design better diagnostic and therapeutic approaches for their clinical management and patient benefit.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
DVL1; PDZ domain; β-catenin; Wnt signaling pathway; intracranial meningioma; microglia; glioblastoma; olfactomedin-like 3; TGFβ; Glioblastoma; Doublecortin; DCX; OLIG2; NES; single cell RNA-seq; immunohistochemistry; immunofluorescence; brain tumours; brain tumor; GBM; cancer stem cell; BIRC3; BMP4; stemness; pediatric glioblastoma; temozolomide; NKCC1; KCC2; EZH2; PCNA; CAM; cancer; neurodegeneration; glioma; Drosophila; disease model; PI3K; EGFR; genetics; schwannoma; NF2; bevacizumab; VEGF; SH3PXD2A-HTRA1 fusion; molecular targeted therapy; IDH1 mutation; glioma; redox household; nicotinamide phosphoribosyltransferase; NAD+ synthesis; glioblastoma; cancer metabolism; pentose phosphate pathway; cell proliferation; miRNA; hypoxia; angiogenesis; glioma; glioma; treatment-related changes; true progression; pseudoprogression; radiation necrosis; biomarkers; 18F-FET PET; IDH mutation; functional precision oncology; glioblastoma; drug sensitivity; glioblastoma; prognostic biomarkers; systematic review; meta-analysis; glioblastoma; cancer pathway; mRNA; multicriterial analysis; n/a